-dkk
-
Date:-Time:Latest report:-List:First NorthTicker:ONXEO
Market Cap:- mdkkEnterprise Value:- mdkkNet Sales:- meurEarnings:- meurEmployees:0ISIN:FR0010095596

Ratios

10-year key figure history for Onxeo turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Onxeo with index and moving average MA50 and MA200.

Stockprice:-
MA50:-
MA200:-
Price/MA200:-
RSI (14):-
Price/MA50:-

Description

Valerio Therapeutics is a clinical-stage biotechnology company designing and developing novel oncology drugs targeting tumor DNA repair functions. Its therapeutic strategy focuses on fighting tumor resistance to treatments, which poses ever-greater therapeutic challenges, especially in aggressive or rare cancers. its approach is based upon unique mechanisms of action on DNA Damage Response. The company focuses on bringing first-in-class and disruptive compounds from preclinical research to proof-of-concept in man in cancer indications with high unmet needs.

Pharmaceuticals